The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The first instance of transmission of echinocandin resistance in C. auris was reported with the emergence of pan-resistant C. auris in US healthcare settings [16].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [16]
Experimental — accuracy not yet measuredIn the citing paper
“It is important to note that these patients all had prior epidemiological links to health care facilities but no prior echinocandin exposure (32).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [32]
In the citing paper
“Recently, some C. auris isolates were classified as pan-drug-resistant, tolerating all available antifungal drugs [12,13].”
From Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Self-citationCandida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
Ostrowsky, B. E., Greenko, J. A., Adams, E. H., Quinn, M., O’Brien, B., Chaturvedi, V. P., Berkow, E. L., Vallabhaneni, S., Forsberg, K., Chaturvedi, S., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6901a2 · Cited by 247
Self-citationPan-resistant Candida auris: New York subcluster susceptible to antifungal combinations
O'Brien, B., Liang, J., Chaturvedi, S., Jacobs, J. L., & Chaturvedi, V. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30090-2 · Cited by 60
2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection
Southwick, K., Adams, E. H., Greenko, J., Ostrowsky, B., Fernandez, R., Patel, R., Quinn, M., Vallabhaneni, S., Denis, R. J., Erazo, R., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy210.1695 · Cited by 26
Forsberg, K., Lyman, M., Chaturvedi, S., Schneider, E., Fischer, J., Baynham, D., Dunbar, D. F., Plehn, M., Podzorski, D. S., Gumbis, S., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa439.465 · Cited by 5
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–104 of 104
Candidozyma auris utilizes transferrin, but not heme-bound iron for in vivo virulencePreprint
Arekar, T., Katikaneni, D. S., Acharya, T., Horst, K., Zhao, G., Garcia, G., Hernalsteen, S., Weber, C. K., Gour, A., Punshnon, T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731159
Osama, D., Alsedawy, M., Hussein, M. S., Hassan, M. A., Elrefaey, S. M., & Tawfick, M. M. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02393-9
Parallel evolution under constraint shapes echinocandin resistance in Candida aurisPreprint
Cauldron, N. C., Dort, E. N., Weeks, G., Rogers, P. D., & Cuomo, C. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.30.748140
Gifford, H., Pradhan, A., Caswall, B. A., Murphy, S. E., Leaves, I., Edmondson, M. B., Chakraborty, T., Wilson, D., Taori, S. K., Gow, N. A. R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76954-x · Cited by 1
Metadata
- Authors
- Lyman, M., Forsberg, K., Reuben, J., Dang, T., Free, R., Seagle, E. E., Sexton, D. J., Soda, E., Jones, H., Hawkins, D., Anderson, A., Bassett, J., Lockhart, S. R., Merengwa, E., Iyengar, P., Jackson, B. R., & Chiller, T.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Digital China Health (China) (CN)
- Texas Department of State Health Services (US)
- Corresponding author
- Lyman, Meghan
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 29
- Pages
- 1022-1023
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC8297693
- OpenAlex
- W3186384872
- Cited by
- 104
- References
- 6
- Citations by year
- 2026: 19 · 2025: 12 · 2024: 20 · 2023: 23 · 2022: 20 · 2021: 10
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Candida auris, echinocandin resistance, fungemia, nosocomial transmission, healthcare facilities, antimicrobial resistance, Texas, Washington, D.C.
- MeSH terms
- Amphotericin B, Antifungal Agents, Azoles, Candida, Cross Infection, District of Columbia, Humans, Texas, Drug Resistance, Multiple, Fungal, Echinocandins, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
